GlassScriptPhysician profile
Ella Little
NPI 1275220410
$572.13
in general payments reported to CMS, 2019-2025
11 companies · $287 in 2025
The $287 reported for 2025 was more than what 84% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $153 · 2024: $132 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $195.30 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $113.09 | 2023-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Pfizer INC. | $63.43 | 2023-2025 | |
| Ironshore Pharmaceuticals INC. | $60.06 | 2023 | Jornay Pm |
| Aytu Biopharma, INC. | $33.73 | 2024-2025 | Karbinal |
| Ars Pharmaceuticals Operations, INC. | $21.71 | 2025 | Neffy |
| Cranial Technologies, INC | $20.58 | 2025 | Doc Band |
| Seqirus USA INC | $20.56 | 2024 | Flucelvax |
| Corium, LLC | $15.75 | 2023 | Azstarys |
| Sobi, INC | $14.03 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2024 | Flumist Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ella Little listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.